964 related articles for article (PubMed ID: 29581214)
1. Effect of Lowering Diastolic Pressure in Patients With and Without Cardiovascular Disease: Analysis of the SPRINT (Systolic Blood Pressure Intervention Trial).
Khan NA; Rabkin SW; Zhao Y; McAlister FA; Park JE; Guan M; Chan S; Humphries KH
Hypertension; 2018 May; 71(5):840-847. PubMed ID: 29581214
[TBL] [Abstract][Full Text] [Related]
2. Assessment of Risk of Harm Associated With Intensive Blood Pressure Management Among Patients With Hypertension Who Smoke: A Secondary Analysis of the Systolic Blood Pressure Intervention Trial.
Scarpa J; Bruzelius E; Doupe P; Le M; Faghmous J; Baum A
JAMA Netw Open; 2019 Mar; 2(3):e190005. PubMed ID: 30848803
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Optimal Diastolic Blood Pressure Range Among Adults With Treated Systolic Blood Pressure Less Than 130 mm Hg.
Li J; Somers VK; Gao X; Chen Z; Ju J; Lin Q; Mohamed EA; Karim S; Xu H; Zhang L
JAMA Netw Open; 2021 Feb; 4(2):e2037554. PubMed ID: 33595663
[TBL] [Abstract][Full Text] [Related]
4. Diastolic Hypotension May Attenuate Benefits from Intensive Systolic Targets: Secondary Analysis of a Randomized Controlled Trial.
Lee TC; Cavalcanti RB; McDonald EG; Pilote L; Brophy JM
Am J Med; 2018 Oct; 131(10):1228-1233.e1. PubMed ID: 29906425
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular Risk in Hypertension in Relation to Achieved Blood Pressure Using Automated Office Blood Pressure Measurement.
Myers MG; Kaczorowski J; Dolovich L; Tu K; Paterson JM
Hypertension; 2016 Oct; 68(4):866-72. PubMed ID: 27528062
[TBL] [Abstract][Full Text] [Related]
6. Influence of baseline systolic blood pressure on the relationship between intensive blood pressure control and cardiovascular outcomes in the Systolic Blood Pressure Intervention Trial (SPRINT).
Sun X; Guo Y; Nie Z; Cheng J; Zhou H; Zhong X; Zhang S; Du Z; Zhuang X; Liao X
Clin Res Cardiol; 2019 Mar; 108(3):273-281. PubMed ID: 30167807
[TBL] [Abstract][Full Text] [Related]
7. No evidence for a J-shaped curve in treated hypertensive patients with increased cardiovascular risk: The VALUE trial.
Kjeldsen SE; Berge E; Bangalore S; Messerli FH; Mancia G; Holzhauer B; Hua TA; Zappe D; Zanchetti A; Weber MA; Julius S
Blood Press; 2016; 25(2):83-92. PubMed ID: 26511535
[TBL] [Abstract][Full Text] [Related]
8. Effect of intensive blood pressure lowering on cardiovascular outcomes based on cardiovascular risk: A secondary analysis of the SPRINT trial.
Attar A; Sayadi M; Jannati M
Eur J Prev Cardiol; 2019 Feb; 26(3):238-245. PubMed ID: 30256671
[TBL] [Abstract][Full Text] [Related]
9. On-treatment diastolic blood pressure and prognosis in systolic hypertension.
Fagard RH; Staessen JA; Thijs L; Celis H; Bulpitt CJ; de Leeuw PW; Leonetti G; Tuomilehto J; Yodfat Y
Arch Intern Med; 2007 Sep; 167(17):1884-91. PubMed ID: 17893310
[TBL] [Abstract][Full Text] [Related]
10. Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial).
Soliman EZ; Ambrosius WT; Cushman WC; Zhang ZM; Bates JT; Neyra JA; Carson TY; Tamariz L; Ghazi L; Cho ME; Shapiro BP; He J; Fine LJ; Lewis CE;
Circulation; 2017 Aug; 136(5):440-450. PubMed ID: 28512184
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of blood pressure-lowering treatment by the levels of baseline Framingham risk score: A post hoc analysis of the Systolic Blood Pressure Intervention Trial (SPRINT).
Zhang L; Sun X; Liao L; Zhang S; Zhou H; Zhong X; Zhuang X; Liao X
J Clin Hypertens (Greenwich); 2019 Dec; 21(12):1813-1820. PubMed ID: 31670874
[TBL] [Abstract][Full Text] [Related]
12. [The SPRINT Research. A Randomized Trial of Intensive versus Standard Blood-Pressure Control].
Widimský J
Vnitr Lek; 2016 Jan; 62(1):44-7. PubMed ID: 26967236
[TBL] [Abstract][Full Text] [Related]
13. Influence of Baseline Diastolic Blood Pressure on Effects of Intensive Compared With Standard Blood Pressure Control.
Beddhu S; Chertow GM; Cheung AK; Cushman WC; Rahman M; Greene T; Wei G; Campbell RC; Conroy M; Freedman BI; Haley W; Horwitz E; Kitzman D; Lash J; Papademetriou V; Pisoni R; Riessen E; Rosendorff C; Watnick SG; Whittle J; Whelton PK;
Circulation; 2018 Jan; 137(2):134-143. PubMed ID: 29021322
[TBL] [Abstract][Full Text] [Related]
14. The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT).
Ambrosius WT; Sink KM; Foy CG; Berlowitz DR; Cheung AK; Cushman WC; Fine LJ; Goff DC; Johnson KC; Killeen AA; Lewis CE; Oparil S; Reboussin DM; Rocco MV; Snyder JK; Williamson JD; Wright JT; Whelton PK;
Clin Trials; 2014 Oct; 11(5):532-46. PubMed ID: 24902920
[TBL] [Abstract][Full Text] [Related]
15. Potential Deaths Averted and Serious Adverse Events Incurred From Adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) Intensive Blood Pressure Regimen in the United States: Projections From NHANES (National Health and Nutrition Examination Survey).
Bress AP; Kramer H; Khatib R; Beddhu S; Cheung AK; Hess R; Bansal VK; Cao G; Yee J; Moran AE; Durazo-Arvizu R; Muntner P; Cooper RS
Circulation; 2017 Apr; 135(17):1617-1628. PubMed ID: 28193605
[TBL] [Abstract][Full Text] [Related]
16. On-Treatment Blood Pressure and Cardiovascular Outcomes in Older Adults With Isolated Systolic Hypertension.
Yano Y; Rakugi H; Bakris GL; Lloyd-Jones DM; Oparil S; Saruta T; Shimada K; Matsuoka H; Imai Y; Ogihara T
Hypertension; 2017 Feb; 69(2):220-227. PubMed ID: 28049699
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study.
Vidal-Petiot E; Ford I; Greenlaw N; Ferrari R; Fox KM; Tardif JC; Tendera M; Tavazzi L; Bhatt DL; Steg PG;
Lancet; 2016 Oct; 388(10056):2142-2152. PubMed ID: 27590221
[TBL] [Abstract][Full Text] [Related]
18. Orthostatic Hypotension in the ACCORD (Action to Control Cardiovascular Risk in Diabetes) Blood Pressure Trial: Prevalence, Incidence, and Prognostic Significance.
Fleg JL; Evans GW; Margolis KL; Barzilay J; Basile JN; Bigger JT; Cutler JA; Grimm R; Pedley C; Peterson K; Pop-Busui R; Sperl-Hillen J; Cushman WC
Hypertension; 2016 Oct; 68(4):888-95. PubMed ID: 27504006
[TBL] [Abstract][Full Text] [Related]
19. Effect of Intensive Blood Pressure Treatment on Heart Failure Events in the Systolic Blood Pressure Reduction Intervention Trial.
Upadhya B; Rocco M; Lewis CE; Oparil S; Lovato LC; Cushman WC; Bates JT; Bello NA; Aurigemma G; Fine LJ; Johnson KC; Rodriguez CJ; Raj DS; Rastogi A; Tamariz L; Wiggers A; Kitzman DW;
Circ Heart Fail; 2017 Apr; 10(4):. PubMed ID: 28364091
[TBL] [Abstract][Full Text] [Related]
20. Low Diastolic Blood Pressure is Not Related to Risk of First Episode of Stroke in a High-Risk Population: A Secondary Analysis of SPRINT.
Sobieraj P; Lewandowski J; Siński M; Symonides B; Gaciong Z
J Am Heart Assoc; 2019 Feb; 8(4):e010811. PubMed ID: 30744452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]